𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inhibition of platelet-derived mitogen release by nitric oxide (EDRF)

✍ Scribed by M. L. Barrett; A. L. Willis; J. R. Vane


Publisher
SP Birkhäuser Verlag Basel
Year
1989
Tongue
English
Weight
301 KB
Volume
27
Category
Article
ISSN
1420-908X

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Inhibition of nitric oxide release by an
✍ Dr Takako Yokozawa; Tian Shan Wang; Cui Ping Chen; Masao Hattori 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

An aqueous extract of Tinospora tuberculata stems was found to scavenge nitric oxide (NO) in vitro in both cell and cell-free systems. When the aqueous extract was added to lipopolysaccharide-stimulated murine macrophages, it inhibited NO release dose-dependently, and similar activity was found in a

Synthesis of nitric oxide releasing, vas
✍ Dimitrios Tsikas; Dirk O. Stichtenoth; Rainer H. Böger; Stefanie M. Bode-Böger; 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 French ⚖ 336 KB

## Abstract [^15^N]Nitric oxide (^15^NO) was produced in a “gas‐tight” flask from [^15^N]nitrite by reaction with iodide in acetic acid acidified water and purged for 60 min by a continuous nitrogen gas stream applied through an uncoated polytetrafluoroethylene flate membrane into a second flask wh

Inhibition of superoxide and nitric oxid
✍ Ji-Feng Wang; Pavel Komarov; Helmut Sies; Dr. Herbert de Groot 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 549 KB

Luminol chemiluminescence in phorbolester-activated cultured rat liver Kupffer cells was strongly inhibited by the selenoorganic compound ebselen (IC50 = 2 mumol/L). Ebselen (2-phenyl-1,2-benzisoselenazol-3[2H]one) also diminished reduction of ferricytochrome c (IC50 = 10 mumol/L), indicating a supp

Biology and chemistry of the inhibition
✍ Hans Matter; Peter Kotsonis 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 448 KB

## Abstract Inhibitors of the family of nitric oxide synthases (NOS‐I–III; EC 1.14.13.39) are of interest as pharmacological agents to modulate pathologically high nitric oxide (NO) levels in inflammation, sepsis, and stroke. In this article, we discuss the approach for targeting the unique (__6R__